there is disclosed antibody molecules containing at least one cdr derived from a mouse monoclonal antibody having specificity for human cd22 . there is also disclosed a cdr grafted antibody wherein at least one of the cdrs is a modified cdr . further disclosed are dna sequences encoding the chains of the antibody molecules , vectors , transformed host cells and uses of the antibody molecules in the treatment of diseases mediated by cells expressing cd22 .